Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 176 to 200 of about 5940

Previous 25

Website Changes

04/22/2024

Urgent funding needed for DIPG sonodynamic therapy trial

04/22/2024

Gene Therapy Is Halting Cancer - Can It Work Against Brain Tumors?

04/22/2024

ROSALIE Trial of EO2401/Nivolumab/Bevacizumab in Recurrent Glioblastoma Concludes

04/15/2024

Ivy Brain Tumor Center Announces Promising Results of Phase 0/1 Glioblastoma Study at AACR Annual Meeting

04/15/2024

Upcoming Musella Foundation May Webinars!

04/15/2024

UCLA Brain Tumor Center to Host 24th Annual UCLA Brain Tumor Conference

04/15/2024

`The Brain Surgeon`s Take` podcast episode with Dr. Al Musella on the Promising Pathway Act

04/11/2024

Evaluation of the EMulate Therapeutics Voyager`s ultra-low radiofrequency energy in murine model of glioblastoma

04/08/2024

Real-world cost-effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China

04/05/2024

Sex differences in adverse events in Medicare individuals > 66 years of age post glioblastoma treatment

04/03/2024

Tumor Takedown Fundraiser: Cape Coral, FL May 4, 2024

04/01/2024

Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide

04/01/2024

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

03/30/2024

Low-Grade Glioma Webinar TOMORROW

03/29/2024

Prolonged use of certain hormone drugs linked to increased brain tumor risk

03/29/2024

Advocacy Alert for Washington Residents! Comment publicly to support Washington State HCA coverage of Tumor Treating Fields

03/28/2024

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

03/28/2024

First Participant Receives Sonodynamic Therapy for Glioblastoma in New Clinical Trial

03/25/2024

Oncovir Inc. is Pushing the Boundaries of Medical Innovation with Hiltonol

03/25/2024

Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta

03/25/2024

Bill would allow treatment for terminally ill before FDA approval

03/18/2024

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

03/18/2024

The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database

03/18/2024

Hoops For Hannah: , a March Madness bracket contest!

03/17/2024

Musella Foundation Copay Program now closed to new and renewal patients

Our privacy / cookie policy has changed.
Click HERE to read it!